SMART G-Rex® & SensoRex™ Technology for In-line, Non-Invasive, and Real-Time Monitoring of TIL Expansion

Overview
SMART G-Rex® technology enabled sampling-free tracking of TIL expansion, generating growth curves that reflect both cell growth kinetics and culture quality throughout manufacturing. In the pre-REP, a target of 142 ± 0.5 MHz identified cultures ready for an early harvest yielding 300 to 500 × 10⁶ TIL.
What this paper found
Frequency readings taken through the vessel wall can say when a tumor-infiltrating lymphocyte culture is ready to harvest, without opening it. Both expansion phases of the CTMC platform were followed. First-phase cultures were started in SMART G-Rex®100M-TF from one stage IV melanoma using 5, 10 or 30 tumor fragments, and the Rapid Expansion Protocol was tracked in G-Rex®100M across five lines, with counts extrapolated to G-Rex®500M. In the first phase a reading of 142 ± 0.5 MHz marked cultures that would give 300 to 500 × 10⁶ cells on the same day, a call glucose could not make. In the Rapid Expansion Protocol, 141 ± 0.5 MHz flagged lines a day before plateau, pointing to harvest on Day 10 to 12.
Study details
- Authors
- Marie-Andrée Forget, Tamara Griffiths, Anindita Ravindran, Aemilia Katzinski, Donastas Sakellariou-Thompson, Siddhartha Arora, Andrew Scheffler, Dan Fick, Jon Pileggi, Chantale Bernatchez
- Institution
- CTMC, Houston, TX, USA · ScaleReady, New Brighton, MN, USA
- Journal
- Journal for ImmunoTherapy of Cancer
- Year
- 2026
- G-Rex® model(s)
- G-Rex®100M
- Cell type(s)
- TIL Cells
- Application area
- Solid tumor
- Study phase
- Preclinical
How G-Rex® was used
First-phase expansion ran in SMART G-Rex®100M-TF vessels, whose built-in sensors are read in line on the SensoRex™ reader, so growth is followed with no sampling and no disturbance to the culture. Three cultures were started from a single stage IV melanoma with 5, 10 or 30 tumor fragments, fed on Day 4 and read daily; the target that came out of them was then used ahead of time on Day 9, on a metastatic head and neck tumor and a second stage IV melanoma, to pick cultures for an early harvest. For the Rapid Expansion Protocol, five TIL lines were activated and expanded in G-Rex®100M beside a six-well G-Rex® plate, one well harvested and counted each day so the count could be extrapolated to the bioreactor, while the SMART G-Rex® itself was read daily.
Explore related
Full citation
Forget MA, Griffiths T, Ravindran A, et al. SMART G-Rex® & SensoRex™ technology for in-line, non-invasive, and real-time monitoring of TIL expansion. J Immunother Cancer. 2026;14(Suppl 2):A385.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.